Skip to content

Abstract 11383: Disseminated Verruconis gallopava Central Nervous System Infection Following Orthotopic Heart Transplantation

Nov 2026 · Circulation · 0 citations

Abstract

Introduction: Verruconis gallopava is a rare fungal mold associated with invasive disease in immunocompromised patients, such as transplant recipients. Dissemination to the central nervous system (CNS) has high mortality, resulting in difficult treatment decisions in complex patients. Patient Information: We present a 50-year-old male with end stage non-ischemic cardiomyopathy who received an orthotopic heart transplant (OHT) without complication. His past medical history included type 2 diabetes mellitus, deep vein thrombosis, iron deficiency anemia, and latent tuberculosis treated one year prior. Induction therapy included basiliximab 20mg intraoperatively and four days post transplantation. Discharge immunosuppression regimen was typical with prednisone taper, tacrolimus, and mycophenolate mofetil plus trimethoprim-sulfamethaxazole and valgancicyclovir for prophylaxis. Clinical Findings and Timeline: Nine months post OHT, computed tomography scans, obtained due to routine chest x-ray abnormality, showed enlarging pulmonary nodules in the right lower lobe. Although the patient was asymptomatic, routine endomyocardial biopsy (EMB) also revealed 2R moderate acute cellular mediated rejection with interstitial lymphocytic infiltrate. Diagnostic Assessment and Reasoning: Differentials for the pulmonary nodules included post-transplant lymphoproliferative disorder (PTLD) or an opportunistic infection. Initial cytology of bronchoalveolar lavage samples suggested Blastomycosis . However, his Beta-D-glucan was elevated at 194 pg/mL, transbronchial biopsy revealed dematiaceous mold, and fungal PCR was positive for Verruconis gallopava. A subsequent brain magnetic resonance imaging (MRI) demonstrated a 9x7x7 mm irregular enhancement with vasogenic edema in the right frontal lobe, confirming dissemination. Therapeutic Interventions: After identification of the fungus, oral itraconazole 200mg twice daily was initiated with ongoing high dose steroid therapy for rejection. Once the brain abscess was identified, he transitioned to oral voriconazole 200mg twice daily given its ideal penetration of the CNS. He remained on the voriconazole regimen 6 months. Outcomes: The brain abscess decreased to 4x4x6 mm one month after the initial brain MRI with complete resolution three months after initial presentation. Concurrent rejection was successfully managed with maintenance of graft function and resolution by EMB. Discussion: Disseminated fungal infections in patients with OHT may present with minimal systemic or neurological symptoms while mimicking malignancy or transplant rejection. Tissue cultures and diagnostic imaging were critical for tracking progression of the infection. Early recognition and balanced antifungal and immunosuppression intervention led to resolution of the disseminated CNS infection and maintenance of graft function.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.